(KMJ) – The FDA is recalling 600,000 defective prescription inhalers from GlaxoSmithKline for a “defective delivery system” due to a leak. Reuters reports drugmaker GSK is trying to figure out what caused the problem, and is pulling the inhalers from hospitals, pharmacies, retailers and wholesalers. The recalled inhalers have a lot number of 6ZP9848, 6ZP0003…… MORE